Presentation TCT 2013 The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results Presenter: Martin Leon October 28, 2013
Presentation TCT 2013 Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy Presenter: Raj Makkar October 28, 2013
Presentation TCT 2013 Percutaneous Management of Vascular Complications After TAVR Presenter: Peter Wenaweser October 28, 2013
Presentation TCT 2013 Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II Presenter: Patrick Serruys October 28, 2013
Presentation TCT 2013 Do I Really Need Bioresorbable Scaffolds in the United States? Presenter: Gregg Stone October 28, 2013
Presentation TCT 2013 DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis Presenter: Joachim Schofer October 28, 2013
Presentation TCT 2013 Selecting the Best Antiplatelet Strategy for ACS and Stable CAD Presenter: Oscar Mendiz October 28, 2013
Presentation TCT 2013 Drug-coated Balloons for Bifurcation Lesions: Rationale, Practice, and Evidence Presenter: Kenneth Chin October 28, 2013